Added to YB: 2025-04-10
Pitch date: 2025-02-19
ASRT [bullish]
Assertio Holdings, Inc.
+91.17%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States.
Market Cap
$116.5M
Pitch Price
$12.22
Price Target
3.00 (-87%)
Dividend
N/A
EV/EBITDA
7.16
P/E
-3.80
EV/Sales
0.79
Sector
Pharmaceuticals
Category
value
Show full summary:
Assertio Holdings, Inc. - $ASRT
ASRT: Specialty pharma at 0.2x 2024E sales ($120M), 1.4x EBITDA ($20M). $90M cash for M&A. Rolvedon ($60M run-rate) & Indocin ($25M) lead portfolio. New CEO, refreshed board. Potential catalysts: accretive M&A, Rolvedon growth, asset sales. PT $3 (250% upside). Risks: litigation, bad M&A, Indocin decline.
Read full article (5 min)